PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer [Medical Sciences]

The identification and targeting of key molecular drivers of melanoma and breast and lung cancer have substantially improved their therapy. However, subtypes of each of these three common, lethal solid tumors lack identified molecular drivers, and are thus not amenable to targeted therapies. Here we show that pleckstrin homology domain-interacting...

https://ift.tt/2JRk4Ez